Correction to: Nature Communications 10.1038/s41467-023-39766-x, published online 08 July 2023
In this article, the author name Linda Saf Eldin was incorrectly written as Linda Saifeldin. The original article has been corrected.
. 2024 Jan 8;15:369. doi: 10.1038/s41467-024-44729-x
Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
Suad Hannawi
1, Linda Saf Eldin
2, Alaa Abuquta
1, Ahmad Alamadi
3, Sally A Mahmoud
4, Aala Hassan
1, Shuping Xu
5, Jian Li
5, Dongfang Liu
5, Adam Abdul Hakeem Baidoo
5, Dima Ibrahim
6, Mojtaba Alhaj
7, Yuanxin Chen
5, Qiang Zhou
5, Liangzhi Xie
5,8,✉
Suad Hannawi
1Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
Find articles by Suad Hannawi
Linda Saf Eldin
2General Surgery Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
Find articles by Linda Saf Eldin
Alaa Abuquta
1Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
Find articles by Alaa Abuquta
Ahmad Alamadi
3Ear, Nose and Throat Department (ENT), Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
Find articles by Ahmad Alamadi
Sally A Mahmoud
4Biogenix labs, G42 Healthcare, Dubai, United Arab Emirates
Find articles by Sally A Mahmoud
Aala Hassan
1Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
Find articles by Aala Hassan
Shuping Xu
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Shuping Xu
Jian Li
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Jian Li
Dongfang Liu
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Dongfang Liu
Adam Abdul Hakeem Baidoo
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Adam Abdul Hakeem Baidoo
Dima Ibrahim
6Infectious Diseases Department, Burjeel Medical City, Abu Dhabi, United Arab Emirates
Find articles by Dima Ibrahim
Mojtaba Alhaj
7Research Department, Burjeel Medical City, Abu Dhabi, United Arab Emirates
Find articles by Mojtaba Alhaj
Yuanxin Chen
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Yuanxin Chen
Qiang Zhou
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
Find articles by Qiang Zhou
Liangzhi Xie
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
8Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Find articles by Liangzhi Xie
1Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
2General Surgery Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
3Ear, Nose and Throat Department (ENT), Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates
4Biogenix labs, G42 Healthcare, Dubai, United Arab Emirates
5Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China
6Infectious Diseases Department, Burjeel Medical City, Abu Dhabi, United Arab Emirates
7Research Department, Burjeel Medical City, Abu Dhabi, United Arab Emirates
8Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
✉
Corresponding author.
Collection date 2024.
Subject terms: Viral infection, Drug development
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC10774261 PMID: 38191554
This corrects the article "Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men" in volume 14, 4043.